Hepatitis C in the Context of Drug Use; State-of-the-Art Diagnostic and Pathogenic Efforts
Submitted by Olivia Woodrow
- 9 July 2024
Time: Mon July 22 2024, 12:00 PM ET
Opening Remarks:
Nora Volkow, MD, Director, NIDA
Featured Speakers:
1. Expansion of Point-of-Use Acute HIV infection platform for Hepatitis C Virus
-
Jacqueline C Linnes, PhD, Marta E Gross Professor, Purdue University, West Lafayette, IN
2. Long-term Effects of Intravenous Drug Use, HIV, and HCV, and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
-
Andrea A.Z.Kovacs, MD, Professor of Pediatrics, Pathology and Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA
Discussion:
Moderator: Andrea Cox; MD, PhD, Professor of Medicine, Johns Hopkins School of Public Health, Baltimore, MD
Links